Shalini Sharp, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 2,024 shares at $65.52 ($133K) on 2019-03-05, disclosed to the SEC on 2019-04-17.
Open-market sale of $133k RARE by CFO & Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.52 | 1,012 | $66K | 50.0% |
| 2 | $65.52 | 1,012 | $66K | 50.0% |
| Total | $65.52 avg | 2,024 | $133K | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |